Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-06 @ 8:46 AM
Study NCT ID:
NCT02879760
Status:
COMPLETED
Last Update Posted:
2020-10-06
First Post:
2016-08-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Sponsor:
Turnstone Biologics, Corp.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Ad/MG1-MAGEA3-001 (Sandpiper)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None